郑州大学学报(医学版)
鄭州大學學報(醫學版)
정주대학학보(의학판)
JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES)
2015年
1期
98-101
,共4页
肖静%卢珊%刘栋%张晓雪%王晓阳%胡冬怡%赵占正
肖靜%盧珊%劉棟%張曉雪%王曉暘%鬍鼕怡%趙佔正
초정%로산%류동%장효설%왕효양%호동이%조점정
系统性红斑狼疮%免疫吸附%血液净化
繫統性紅斑狼瘡%免疫吸附%血液淨化
계통성홍반랑창%면역흡부%혈액정화
systemic lupus erythematosus%immunoadsorption%blood purification
目的:探讨DNA免疫吸附治疗重症系统性红斑狼疮( SLE)的临床有效性、安全性。方法:收集重症SLE患者20例,分为观察组(8例)和对照组(12例)。观察组采用连续性血液净化联合DNA免疫吸附配合泼尼松片、环磷酰胺治疗,对照组采用甲强龙冲击后,给予泼尼松片联合环磷酰胺治疗。比较2组患者治疗前及治疗12周、24周SLEDAI评分及ANA、抗ds-DNA抗体滴度,IgG,IgA,IgM,C3,C4,肾功能等指标。结果:与对照组比较,治疗12周观察组SLEDAI评分、ANA与抗ds-DNA抗体滴度下降更快( P均<0.05),24周时观察组ANA滴度仍能维持在较低水平( P均<0.05)。治疗24周,2组患者肾功能均稳定。观察组除1例发生重症感染,无精神异常、心律失常等不良反应发生。结论:DNA免疫吸附治疗重症SLE安全、有效。
目的:探討DNA免疫吸附治療重癥繫統性紅斑狼瘡( SLE)的臨床有效性、安全性。方法:收集重癥SLE患者20例,分為觀察組(8例)和對照組(12例)。觀察組採用連續性血液淨化聯閤DNA免疫吸附配閤潑尼鬆片、環燐酰胺治療,對照組採用甲彊龍遲擊後,給予潑尼鬆片聯閤環燐酰胺治療。比較2組患者治療前及治療12週、24週SLEDAI評分及ANA、抗ds-DNA抗體滴度,IgG,IgA,IgM,C3,C4,腎功能等指標。結果:與對照組比較,治療12週觀察組SLEDAI評分、ANA與抗ds-DNA抗體滴度下降更快( P均<0.05),24週時觀察組ANA滴度仍能維持在較低水平( P均<0.05)。治療24週,2組患者腎功能均穩定。觀察組除1例髮生重癥感染,無精神異常、心律失常等不良反應髮生。結論:DNA免疫吸附治療重癥SLE安全、有效。
목적:탐토DNA면역흡부치료중증계통성홍반랑창( SLE)적림상유효성、안전성。방법:수집중증SLE환자20례,분위관찰조(8례)화대조조(12례)。관찰조채용련속성혈액정화연합DNA면역흡부배합발니송편、배린선알치료,대조조채용갑강룡충격후,급여발니송편연합배린선알치료。비교2조환자치료전급치료12주、24주SLEDAI평분급ANA、항ds-DNA항체적도,IgG,IgA,IgM,C3,C4,신공능등지표。결과:여대조조비교,치료12주관찰조SLEDAI평분、ANA여항ds-DNA항체적도하강경쾌( P균<0.05),24주시관찰조ANA적도잉능유지재교저수평( P균<0.05)。치료24주,2조환자신공능균은정。관찰조제1례발생중증감염,무정신이상、심률실상등불량반응발생。결론:DNA면역흡부치료중증SLE안전、유효。
Aim:To investigate the clinical efficacy and safety of DNA immunoadsorption on patients with severe sys -temic lupus erythematosus ( SLE). Methods: Twenty cases of severe SLE were allocated into 2 groups; observation group (n=8) received continuous blood purification, DNA immunoadsorption and glucocorticoid treatment ,and control group ( n=12 ) received cyclophosphamide combined with glucocorticoid treatment. Before and at 12 and 24 weeks after the ther-apy, SLEDAI score, autoantibodies(ANA) and anti-ds DNA autoantibody titer, IgG, IgA, IgM levels, C3 and C4 and re-nal function parameters were assessed. Results:At 12 weeks after the treatment, the SLEDAI score, ANA and anti-dsD-NA autoantibody titer in the observation group decreased more significantly than control group ;at 24 weeks after the treat-ment, the ANA titer in the observation group still maintained in a low level (P<0.05).The renal function were stable in two groups during 24 weeks. There were no obvious side effects except for a case of severe infection. Conclusion:DNA immunoadsorption in treatment of severe SLE is effective and safe.